NeueHealth Statistics
Total Valuation
NeueHealth has a market cap or net worth of $31.53 million. The enterprise value is $58.56 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NeueHealth has 8.25 million shares outstanding. The number of shares has increased by 2.79% in one year.
| Current Share Class | 8.25M |
| Shares Outstanding | 8.25M |
| Shares Change (YoY) | +2.79% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 7.69% |
| Owned by Institutions (%) | 12.51% |
| Float | 3.37M |
Valuation Ratios
The trailing PE ratio is 1.12.
| PE Ratio | 1.12 |
| Forward PE | n/a |
| PS Ratio | 0.03 |
| Forward PS | 0.12 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.68
| Current Ratio | 0.68 |
| Quick Ratio | 0.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -5.10% |
| Return on Capital (ROIC) | -34.76% |
| Revenue Per Employee | $796,238 |
| Profits Per Employee | -$329,645 |
| Employee Count | 1,252 |
| Asset Turnover | 0.72 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NeueHealth has paid $4.86 million in taxes.
| Income Tax | 4.86M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.80% in the last 52 weeks. The beta is 0.79, so NeueHealth's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -30.80% |
| 50-Day Moving Average | 5.10 |
| 200-Day Moving Average | 5.58 |
| Relative Strength Index (RSI) | 29.70 |
| Average Volume (20 Days) | 9,159 |
Short Selling Information
The latest short interest is 26,788, so 0.32% of the outstanding shares have been sold short.
| Short Interest | 26,788 |
| Short Previous Month | 30,580 |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.80% |
| Short Ratio (days to cover) | 2.85 |
Income Statement
In the last 12 months, NeueHealth had revenue of $996.89 million and -$412.72 million in losses. Loss per share was -$50.65.
| Revenue | 996.89M |
| Gross Profit | 174.78M |
| Operating Income | -112.21M |
| Pretax Income | -994.38M |
| Net Income | -412.72M |
| EBITDA | -90.28M |
| EBIT | -112.21M |
| Loss Per Share | -$50.65 |
Full Income StatementBalance Sheet
The company has $118.68 million in cash and $136.87 million in debt, giving a net cash position of -$27.03 million or -$3.27 per share.
| Cash & Cash Equivalents | 118.68M |
| Total Debt | 136.87M |
| Net Cash | -27.03M |
| Net Cash Per Share | -$3.27 |
| Equity (Book Value) | -312.52M |
| Book Value Per Share | -163.68 |
| Working Capital | -283.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$430.05 million and capital expenditures -$1.81 million, giving a free cash flow of -$431.86 million.
| Operating Cash Flow | -430.05M |
| Capital Expenditures | -1.81M |
| Free Cash Flow | -431.86M |
| FCF Per Share | -$52.33 |
Full Cash Flow StatementMargins
Gross margin is 17.53%, with operating and profit margins of -11.26% and -36.28%.
| Gross Margin | 17.53% |
| Operating Margin | -11.26% |
| Pretax Margin | -11.79% |
| Profit Margin | -36.28% |
| EBITDA Margin | -9.06% |
| EBIT Margin | -11.26% |
| FCF Margin | n/a |
Dividends & Yields
NeueHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.79% |
| Shareholder Yield | -2.79% |
| Earnings Yield | -1,309.07% |
| FCF Yield | -1,369.80% |
Analyst Forecast
The average price target for NeueHealth is $7.00, which is 83.25% higher than the current price. The consensus rating is "Hold".
| Price Target | $7.00 |
| Price Target Difference | 83.25% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on May 22, 2023. It was a reverse split with a ratio of 0.0125:1.
| Last Split Date | May 22, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0125:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |